Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | SMO | Q99835 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.45 |
| ▸ | TUBB | P07437 | 5/20 | 0.45 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.45 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.45 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.45 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.45 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.45 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.45 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.45 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.45 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.45 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.45 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.45 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.45 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20116303 | 0.85 | SMN1; SMN2 (0.55) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL20116338 | 0.84 | LMNA (0.53) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL22358304 | 0.79 | SMO (0.48) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL20116613 | 0.76 | SMO (0.53) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL22357902 | 0.75 | SMO (0.52) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL20116501 | 0.74 | SMO (0.49) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL20676564 | 0.74 | SMN1; SMN2 (0.59) | SMN1; SMN2LMNATSHRHTTTUBB4A | |
| SCHEMBL20116945 | 0.74 | GPR119 (0.52) | SMN1; SMN2LMNATSHRTUBB4ATUBB | |
| SCHEMBL20116971 | 0.74 | SMO (0.54) | SMN1; SMN2LMNATSHRSMOHTT | |
| SCHEMBL20676705 | 0.73 | SMO (0.49) | SMN1; SMN2LMNATSHRSMOHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873298-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-16 | — | — | US | disclosed |
| US-11873298-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-16 | — | — | US | disclosed |
| US-20200262828-A1 | COMPOUNDS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-08-20 | — | — | US | disclosed |
| WO-2019209948-A9 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2020-01-02 | — | — | WO | disclosed |
| WO-2019018795-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS (US) | 2019-01-24 | — | — | WO | disclosed |
| WO-2018081167-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS (US) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873298-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | SMN1; SMN2 13/4885LMNA 1966/4885TSHR 4679/4885 |
| US-20200262828-A1 | COMPOUNDS AND USES THEREOF | NLN, ACHE, CLN6 | SMN1; SMN2 13/4885LMNA 1966/4885TSHR 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.